Blog & News

We have a few things to say about prescription savings.
News

Castlight Health and RazorMetrics Join Forces

AUSTIN, Texas, April 26, 2022/PRNewswire/ – Castlight Health is the newest member of RazorMetrics’ Partnership Collective, and RazorMetrics is joining Castlight’s Ecosystem of leading digital health companies. Castlight, a connected health navigation company, offers a world-class digital platform with a team of clinical and benefits experts who help members easily connect with the right programs and care at the right time, delivering better health outcomes and helping to maximize returns on healthcare investments.

Read More »
April 26, 2022 No Comments
Press

Navigating High Drug Costs: Study Finds Consumers Want Their Physician to Lead

RazorMetrics, an innovative healthcare technology company, recently conducted a consumer opinion survey asking about drug costs and found some surprising results. Despite the explosion in consumer-oriented drug savings options – mail-order pharmacy, discount cards, etc. – healthcare consumers want their physician to take the lead on lowering drug costs. The survey found that 80% of respondents would prefer their physician be the one to choose a lower-cost drug for their prescription and do so automatically.

Read More »
April 20, 2022 No Comments
Article

Could Drug Recalls Be Handled Better? Definitely.

Last week, Pfizer voluntarily recalled three of their hypertension drugs, including Accuretic, due to nitrosamine levels in the medication. Nitrosamine is common and safe in low amounts, but the drug pushed people above the acceptable daily intake limit, which increased the risk of cancer down the road.

Read More »
March 31, 2022 No Comments

Sopris Capital Leads $6,000,000 Series A Investment in RazorMetrics

Sopris Capital, a leading healthcare investment firm, is entering the drug cost transparency space with a new partnership with RazorMetrics, a rapidly growing healthcare technology company focused on lowering pharmacy costs for at-risk employers and health plans. The Series A investment of $6,000,000 was led by Sopris and other individual investors including long-term entrepreneurs Joel Trammell and Jonathan Weiner.

Read More »
April 20, 2021 No Comments

Most Popular:

Stop the vicious cycle of increasing drug spend.

We're here to help.
GET STARTED NOW
RazorMetrics™

RazorMetrics dramatically cuts prescription drug costs for self-funded companies, health plans, and their employees or members. 

Linkedin Twitter Telegram

Solutions

About

Resources

Ready to Get Started?

We're Here

To Help You Save

And, we are waiting…
Contact us, and we will be more than happy to answer all of your questions.